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Murine resident peritoneal macrophages are a rich source of arachidonic acid 
(20:4)  metabolites  (1,  2).  When  these  cells phagocytose  zymosan,  or  particles 
coated with  complexes of IgG  or  IgE,  20:4  is  released  from the  macrophage 
membrane phospholipid  by the  reaction of one or more  phospholipases.  The 
released 20:4 is then quantitatively oxygenated via either the cyclooxygenase or 
lipoxygenase pathways  (2,  3).  Interaction  of the  surface-bound  IgG  with  Fc 
receptors is sufficient to trigger both phagocytosis and the release of 20:4 (4). 
Here, we examine two other phagocytosis-promoting receptors, and report that 
the  C3b  and  C3bi  receptors  do  not  initiate  the  release  of 20:4.  Since  these 
receptors do promote phagocytosis, we infer that the intracellular signal leading 
to phospholipase activation is distinct from that leading to engulfment. 
Materials and Methods 
Macrophage Cultures.  Primary cultures of peritoneal macrophages were established 
from resident cells of specific pathogen-free female ICR mice (Trudeau Institute, Saranac 
Lake  NY) weighing  25-30  g,  as previously described (5).  Peritoneal cells  (~9  ×  106 
cells/ml) in minimal essential medium (MEM) (Gibco, Grand Island NY) containing 10% 
fetal calf serum (FCS) were added to 35-ram-diameter plastic culture dishes (1  ml]dish) 
or to  12-ram  glass  coverslips (0.1  ml/slip).  After  2  h  at  37°C  in a  5%  CO~,  95%  air 
atmosphere, cultures were washed three times in calcium- and magnesium-free phosphate 
buffered saline  (depleted phosphate  buffer,  PD),  to remove nonadherent cells.  Fresh 
MEM plus  10%  FCS (1  ml]dish), containing 0.5 #Ci of [5,6,8,9,11,12,14,15JH]arachi  - 
donic acid ([SH]20:4)  (specific activity, 70 Ci]nmol; New England Nuclear, Boston MA) 
was added, and the cells were incubated overnight (16 h). 
Preparation of Ligand-coated Particles.  Glass beads (8 #m, Duke Scientific Corp., Palo 
Alto, CA) were derivitized with dinitrophenyl (DNP), as described previously (6) for glass 
coverslips, and were suspended in phosphate-buffered saline (PBS) at  50  mg]ml.  IgG- 
coated beads (BIgG) or IgM-coated beads (BIgM) were obtained by incubating 10 mg of 
DNP-coated beads in 250 #1 10% FCS for 30 min at 20°C with 25 #g/ml affinity-purified 
rabbit anti-DNP IgG (BIgG) or 3 ul of murine monoclonal anti-DNP IgM ascites fluid 
(BIgM) (7). The beads were then washed three times and suspended at 50 mg]ml in PBS. 
Complement-coated beads (BIgMC) were prepared by incubating BIgM at 25 mg]ml with 
20% normal human serum for 15 min at 37°C followed by three washes in PBS. 
Sheep erythrocytes (SE) were coated with IgM  (EIgM), IgG (EIgG), or human  C3b 
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(EC3b),  or  C3bi,  as  previously described (8).  In  some experiments,  murine  C3  was 
deposited on EIgM by incubating 5 ×  108 celis/ml with 20% mouse serum at 37°C for 15 
min. These cells probably bear both C3b and C3bi and are designated EIgMC. 
Assays of Phagocytosis and Attachment.  Phagocytosis and attachment of ligand-coated 
SE was measured as described (8). The results were scored with a phase-contrast micro- 
scope  by counting the number of SE ingested or attached per  100  phagocytes. These 
numbers  are  termed  phagocytic index  and  attachment  index,  respectively.  In  some 
experiments, ligand-coated glass beads were added with the ligand-coated SE. Under such 
conditions, attachment of SE  to  macrophages could not  be  scored  by phase-contrast 
microscopy. In such cases, the following procedure was used. After a 45 min incubation 
of macrophages with both beads and SE, monolayers were washed, cooled to 0°C, and 
incubated for 30 min with fluoresceinated anti-SE.  The monolayers were washed again, 
and attachment of SE was scored using fluorescence microscopy. The presence of beads 
that did not bear ligand (BIgM) caused a  15% depression in the attachment index of all 
ligand-coated SE. 
Assay of Total [SH]20:4 Release.  Macrophages prelabelled with [SH]20:4 were washed 
four times in PD and were overlaid with 1 ml of serum-free MEM. Zymosan (160 ~g/ml) 
and BIgM, BIgMC, and BIgG (all at 5 mg/ml) were added as indicated. The cells were 
incubated at 37 °C in a 95% air, 5% COe atmosphere, and at the times indicated, aliquots 
of medium were removed and counted in Hydrofluor (National Diagnostics, Inc., Somer- 
ville NJ). The cells were washed in PD and scraped twice into  1 ml of Triton X-100. 
Portions of the cell iysates were assayed for radiolabel content, and protein was determined 
by the method of Lowry et al. (9) with bovine serum albumin as a standard. 
"Activation" of Complement Receptors With Lymphokines.  To obtain cells that were capable 
of ingesting C3-coated particles, macrophage monolayers were incubated at 37°C forl6 
h in supernatants containing a lymphokine secreted by appropriately triggered T lympho- 
cytes (TCF) (generously provided by Dr.  Frank Griffin, University of Alabama in Bir- 
mingham) (10). 
Results 
Macrophages were challenged with glass beads coated with a variety of ligands. 
Since  IgM-coated  glass  surfaces  do  not  promote  the  release  of  H~O~  from 
phagocytes (11), IgM-coated glass beads were chosen as a negative control. BIgM 
bound very well to macrophages, but they neither triggered release of 20:4 nor 
inhibited the release of 20:4 stimulated by zymosan (Fig.  1 A). In keeping with 
previous  findings  (4),  IgG-coated  beads  did  trigger  the  release  of ~12%  of 
cellular 20:4. Complement-coated beads caused no release of cellular 20:4 (Fig. 
1A). 
The  inability of complement-coated  beads  (BIgMC)  to  stimulate  release  of 
20:4  does  not  result  from  insufficient amounts  of the  ligand,  C3.  This  was 
demonstrated by measuring the number of available C3  receptors  on  the  cell 
surface following interaction with ligand-coated beads. While BIgM caused no 
reduction in either C3b or C3bi receptors,  BIgMC caused a  marked reduction 
(~85%) of both C3b and C3bi receptors (Table I). This reduction likely results 
from diffusion of receptors to the glass-adherent surface where they are occupied 
and trapped by interaction with the ligand. Thus, our observations suggest that 
the failure of macrophages to secrete 20:4 in response to BIgMC is not due to 
inefficient interaction between ligand and receptor, rather, ligated C3b and C3bi 
receptors are unable to stimulate secretion of 20:4. 
The resident peritoneal macrophages employed in the above experiment have 
"inactive" complement receptors, i.e. receptors that do not promote phagocytosis 
of C3b- or C3bi-coated particles (12,  13, and Table II). Therefore, it may not ADEREM  ET  AL.  BRIEF  DEFINITIVE  REPORT  619 
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FIGURE  l.  Time course of 20:4  release  in response to  various stimuli.  Macrophages were 
isolated  and  labeled  with  [SH]20:4  for  16  h  in  MEM  plus  10%  FCS  (A),  or  in  culture 
supernatants containing TCF (B).  The cells were  then washed four times with  PD,  overlaid 
with 1 ml MEM, and challenged with  160 ug zymosan (I-'1) or with 5 mg of ligand-coated beads 
(BIgM  [O],  BlgMC  [[2]], BIgG  [A]).  Control  cells receiving  no stimulus (X)  were  similarly 
treated  and  incubated at  37°C  in  a  95%  air,  5%  COs atmosphere.  At the  specified times, 
duplicate aliquots of the medium were removed and counted. The cells were scraped twice in 
0.05%  Triton-X  100, and the radiolabel  and protein content of the cell  lysates were  deter- 
mined. Values are expressed as percent of total  cellular 20:4  released into the medium, and 
are the mean of triplicate cultures. 
TABLE  I 
Complement Receptors Bind to C3 on Complement-coated Glass Beads 
Attachment index 
Ligand-coated  Resident macrophage  TCF-treated macrophage  bead 
EC3b  EC3bi  EIgMC  EIgG  EC3b  EC3bi  EIgMC  EIgG 
BIgM  1,130  1,00g  1,665  650  958  900  1,183  977 
BIgMC  194  164  343  644  172  124  175  1,050 
BIgG  703  820  1,640  350  1,022  800  ND*  222 
Monolayers of macrophages were cultured overnight in MEM plus 10% FCS, or TCF. The monolayers were then 
washed in PBS and incubated for 45 rain at 37 °C with a mixture of the indicated ligand-coated erythrocytes and 
ligand-coated beads as described in  Materials and  Methods. The monolayers were  again washed in  PBS  and 
incubated at 0°C for 30 rain with fluoresceinated antibody directed against sheep erythrocytes. Attachment of 
erythrocytes to macrophages was scored using a fluorescent microscope. 
* Not done. 
TABLE  II 
C3 Receptors of TCF-stimulated Macrophages Promote Phagocytosis 
Ligand-coated erythrocyte 
Phagocytic index 
Resident macrophage  TCF-treated macro- 
phage 
ElgMC  18 (10%)  140 (64%) 
EIgG  480 (86%)  404 (83%) 
EC3b  23 (13%)  72 (34%) 
EC3bi  25 (14%)  91 (46%) 
Monolayers of macrophages were cultured overnight in MEM or TCF as described 
in  Materials  and  Methods.  The  macropbages were  washed and  the  phagocytic 
capacity was determined using the indicated ligand-coated erythrocytes. Results are 
expressed as phagocytic index, and the percent of phagocytes ingesting at least one 
erythrocyte is given in parentheses. Data are averaged from two separate experi- 
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be surprising that these receptors are incapable of promoting the release of 20:4. 
In order to measure the effect of active phagocytosis-promoting C3 receptors on 
the release of 20:4,  we cultured the macrophages for  18  h  in  a  source of an 
activating lymphokine (TCF). Griffin et al. (10, 13) have shown that this lympho- 
kine renders C3  receptors competent to  promote phagocytosis, and Table  II 
shows that complement-mediated phagocytosis is stimulated 7-fold by the con- 
ditions we employed. Nevertheless, BIgMC triggered no release of 20:4  from 
iymphokine-stimulated macrophages (Fig.  1 B). Thus, C3 receptors signal phag- 
ocytosis without signalling the release of 20:4 from peritoneal macrophages. 
Though C3 receptors of resident peritoneal macrophages may not themselves 
promote phagocytosis, Ehlenberger and Nussenzweig (12) have shown that C3 
receptors  can  act  synergistically with  Fc  receptors  to  promote  phagocytosis. 
Therefore, we examined the ability of C3 receptors to augment the release of 
20:4 stimulated by BIgG and zymosan. In unstimulated macrophages, saturating 
doses  of BIgG  and  zymosan individually promote  the release  of 10-20%  of 
cellular 20:4  (Fig.  1 A). A  combined stimulus of zymosan plus BIgG provokes 
the release of an amount of 20:4  equal to the sum of the release triggered by 
either zymosan or BIgG alone (Fig. 1 A). This observation demonstrates that the 
engagement of either the Fc receptor, or those receptors that bind zymosan, 
does not exhaust the capacity of the macrophage to release 20:4, and that these 
receptors act in an additive manner. Engagement of C3 receptors by BIgMC, on 
the other hand, causes no augmentation of the release of 20:4 initiated by either 
BIgG or zymosan (Fig.  1 A).  Thus,  C3  receptors appear incapable of synergy 
with Fc receptors, or with those receptors that bind zymosan. 
Even though treatment of macrophages with lymphokine does not enable the 
C3 receptors to promote the release of 20:4, it does induce the cells to secrete 
double the amount of 20:4 in response to zymosan (Fig.  1, A and B). In contrast, 
the Fc receptor-mediated release of 20:4 is unaffected by this treatment (Fig.  1, 
A and B). 
Discussion 
Macrophages express receptors for the principle opsonic molecules in mam- 
mals,  IgG  and  C3  (14).  Both  the  Fc  and  C3  receptors  are  transmembrane 
glycoproteins which bind appropriately opsonized particles, and which are capa- 
ble of initiating changes in cellular behavior (14).  Ligation of Fc receptors by 
IgG-coated particles results not only in phagocytosis of the particle, but also in 
the concomitant release of H202  and 20:4 (2,  14).  C3 receptors differ from Fc 
receptors in  several  respects.  While  the  Fc  receptor is  composed of a  single 
polypeptide chain of ~55 kD (14), the C3 receptors are much larger. The C3b 
receptor is a  190  kD protein (15),  and the C3bi  receptor is composed of two 
polypeptide  chains  of  190  and  105  kD  (16).  Consonant  with  the  structural 
difference between Fc and C3 receptors is their different behavior. C3 receptors 
can exist in  two states,  an  inactive state,  in  which the C3  receptors bind  C3- 
coated particles but do not promote their ingestion, and an active state, in which 
particle  binding  is  followed by  phagocytosis (13).  Resting  macrophages bear 
inactive receptors that can be converted by the action of a  iymphokine to the 
activated state (13). Second, while C3 receptors do promote phagocytosis, they ADEREM ET AL.  BRIEF  DEFINITIVE REPORT  621 
do not trigger the release of H~O~ (11, 17), and we report here that they do not 
cause the secretion of 20:4 metabolites. 
The observation that C3  receptors do not promote the release of 20:4 and 
H~O~ suggests that complement-mediated phagocytosis may provide a means of 
clearing opsonized particles without initiating or perpetuating an inflammatory 
response. 
The inability of the C3 receptors to promote the release of 20:4  and H202 
may also  provide  insight  into  the  mechanisms by  which  receptor  ligation  is 
coupled  to  metabolic  responses.  The  Fc  receptor  initiates  phagocytosis,  the 
secretion of H202,  and the release of 20:4  (2,  14).  Are these three responses 
triggered by a common intracellular signal, or are separate signals required for 
each? We have previously shown that C3 receptors initiate phagocytosis without 
triggering the release of H202 (11). Thus, it appears that the signals for secretion 
of H202 and for phagocytosis are functionally distinct. Similarly, we show here 
that C3 receptors promote phagocytosis without triggering the release of 20:4, 
suggesting that the signal for phagocytosis and for 20:4 release are also distinct. 
Recent evidence from this laboratory suggests that the signals for 20:4 release 
and for H202 secretion are also distinct, as they differ in their requirement for 
extracellular Na  +.  This is  inferred from ion-replacement studies,  which show 
that the signal(s) between the receptor and the phospholipase is interrupted by 
the removal of Na  + from the medium, while Fc receptor-induced H202 secretion 
is unaffected (18, and A. Aderem et al., manuscript in preparation). 
Since each of the three cellular responses to Fc receptor iigation appears to be 
triggered by a  distinct intracellular signal,  we speculate that  Fc receptors can 
generate at least three separate signals. We wish to point out, however, that "the 
signal" that initiates a complex biological process such as the release of 20:4 need 
not be synonymous with a  single intracellular second messenger such as Ca  u+, 
cyclic nucleotides, or diacylglycerol. The initiation of such a cellular process may 
require the simultaneous presence of two or more second messengers or, more 
likely, a defined sequence of events, mediated by two or more second messengers. 
The pathway by which Fc receptors initiate release of 20:4  is currently under 
study. 
Summary 
Receptors for IgG stimulate the release of ~20% of cellular arachidonic acid 
(20:4) from murine resident peritoneal macrophages. In contrast, C3 receptors 
do not trigger the secretion of any 20:4 in excess of that released constitutively 
from the  cells.  Since the ability of C3  receptors to  promote phagocytosis is 
regulated, we compared resting macrophages, whose C3 receptors do not pro- 
mote phagocytosis of C3-coated particles, and lymphokine-treated cells, whose 
receptors do promote ingestion.  Despite their ability to promote phagocytosis, 
the C3 receptor of lymphokine-treated macrophages remain unable to initiate 
release of 20:4. We speculate that the intracellular signals that initiate phagocy- 
tosis are distinct from those that initiate release of 20:4. 
We thank David Sniadack for technical asssistance. 
Received  for publication  26 November 1984. 622  ADEREM  ET  AL.  BRIEF  DEFINITIVE REPORT 
References 
1.  Scott, W. A.,J. M. Zrike, A. L. Hamill,J. Kempe, and Z. A. Cohn.  1980. Regulation 
of arachidonic acid metabolites in macrophages. J. Exp. Med. 152:324. 
2.  Bonney,  R. J.,  P.  Naruns,  P.  Davies,  and J.  L.  Humes.  1979.  Antigen-antibody 
complexes stimulate the synthesis and release of prostaglandins by mouse peritoneal 
macrophages. Prostaglandins.  18:605. 
3.  Rouzer, C. A., W.  A. Scott,  Z.  A. Cohn,  P.  Blackburn, and J.  M.  Manning.  1980. 
Mouse peritoneal  macrophages release  leukotriene  C  in  response to a  phagocytic 
stimulus. Proc. Natl. Acad. Sci. USA. 77:4928. 
4.  Rouzer, C. A., W. A. Scott, J. Kempe, and Z. A. Cohn.  1980. Prostaglandin synthesis 
by macrophages requires a specific receptor-ligand interaction. Proc. Natl. Acad. Sci. 
USA. 77:4279. 
5.  Cohn, Z. A., and B. Benson.  1965. The differentiation of mononuclear phagocytes. 
Morphology, cytochemistry, and biochemistry. J. Exp. Med. 121 : 157. 
6.  Michl, J.,  M.  M.  Pieczonka, J.  C.  Unkeless, and S.  C.  Silverstein.  1979.  Effects of 
immobilized immune complexes on Fc- and complement-receptor function in resident 
and thioglycollate-elicited mouse peritoneal macrophages. J. Exp. Med. 150:607. 
7.  Wright,  S.  D.,  and  S.  C.  Silverstein.  1984.  Phagocytosing  macrophages exclude 
proteins from the zones of contact with opsonized targets. Nature (Lond.). 309:359. 
8.  Wright, S. D., and S. C. Silverstein. 1982. Tumor-promoting phorbol esters stimulate 
C3b and C3b' receptor-mediated phagocytosis in cultured human monocytes. J. Exp. 
Med. 156:1149. 
9.  Lowry,  O.  H.,  N. J.  Rosebrough,  A. J.  Farr,  and  R. J.  Randall.  1951.  Protein 
measurement with Folin phenol reagent. J. Biol. Chem. 193:265. 
10.  Griffin,  F.  M., Jr.,  R.  A.  Luben,  and  D.  W.  Golde.  1984.  A  human  lymphokine 
activates macrophage C3 receptors for phagocytosis: Studies using monoclonal anti- 
lymphokine antibodies.J. Leukocyte Biol. 36:95. 
11.  Wright,  S.  D.,  and  S.  C.  Silverstein.  1983.  Receptors for C3b and C3bi  promote 
phagocytosis but not the release of toxic oxygen from human phagocytes. J.  Exp. 
Med. 158:2016. 
12.  Ehlenberger, A. G., and V. Nussenzeig.  1977. The role of membrane receptors for 
C3b and C3d in phagocytosis.J. Exp. Med. 145:357. 
13.  Griffin, J. A., and F. M. Griffin, Jr. 1979. Augmentation of macrophage complement 
receptor function in vitro.  I. Characterization of the cellular interactions required 
for the generation of a T-lymphocyte product that enhances macrophage complement 
receptor function. J. Exp. Med. 150:653. 
14.  Unkeless, J.  C.,  and  S.  D.  Wright.  1984.  Structure  and  modulation  of Fc  and 
complement receptors. In Contemporary Topics in Immunobiology. R. Snyderman, 
editor.  14:171. 
15.  Kinoshita, T., and V. Nussenzweig.  1984. Functional properties of factor H and the 
membrane complement receptor for C3b, C4b (CRI) in mice. Fed. Proc. 43:1491a. 
(Abstr.). 
16.  Beller,  D.  I.,  T.  A.  Springer,  and  R.  D.  Schreiber.  1982.  Anti-Mac-1  selectively 
inhibits  the  mouse  and  human  type  three  complement  receptor. J.  Exp.  Med. 
156:1000. 
17.  Yamamoto,  K.,  and  R.  B. Johnston, Jr.  1984.  Dissociation  of phagocytosis from 
stimulation of the oxidative metabolic burst in macrophages. J. Exp. Med. 159:405. 
18.  Aderem, A. A., W. A. Scott, and Z. A. Cohn.  1984. A selective defect in arachidonic 
acid  release  from macrophage membranes in  high  potassium  media. J.  Cell Biol. 
99:1235. 